ǥ :
|
ȣ - 550740 376 |
Impact of diabetes mellitus on plaque vulnerability and clinical outcome in patients with acute myocardial infarction with plaque rupture |
1전남대학교병원 순환기내과, 2광주기독병원 순환기내과, 3미래로21병원 순환기내과, 4목포한국병원 순환기내과 |
홍영준1, 이승욱2, 이상현3, 정명호1, 최윤하1, 송진아1, 김동한1, 이기홍1, Futoshi Yamanaka1, 이민구1, 박근호1, 심두선1, 김한균4, 윤남식1, 윤현주1, 김계훈1, 박형욱1, 김주한1, 안영근1, 조정관1, 박종춘1, 강정채1 |
Background: We assessed the impact of diabetes mellitus on plaque vulnerability and clinical outcome in 224 acute myocardial infarction (AMI) patients (116 ST segment elevation and 108 non-ST segment elevation AMI, 94 diabetic and 130 non-diabetic patients) with plaque rupture (PR).
Methods: Major intravascular ultrasound (IVUS) findings included multiple ruptured plaques (different PRs separated by a >5-mm length of artery containing smooth lumen contours) and a thrombus. The incidences of no-reflow, stent thrombosis, and 12-month major adverse cardiac event (MACE) including death, MI, target vessel revascularizations were observed.
Results: The presence of multiple PR (62% vs. 31%, p<0.001) and thrombus (74% vs. 54%, p=0.002) were more common in diabetic patients compared with non-diabetic patients. The composite of no-reflow and acute stent thrombosis after stent implantation occurred more frequently in diabetic patients compared with non-diabetic patients (22% vs. 11%, p=0.019) and diabetes mellitus [odds ratio (OR): 2.968, 95% CI: 1.287-6.542, p=0.024) and multiple PR (OR: 3.128, 95% CI: 1.357-6.687, p=0.012) were the independent predictors of the composite of no-reflow and acute stent thrombosis. There was no significant difference in 12-month MACE between diabetic and non-diabetic patients (17% vs. 11%, p=0.18).
Conclusions: Diabetic AMI patients with IVUS-evident PR have more plaque vulnerability (more frequent multiple PR and more thrombus) and have higher incidences of acute complications after stenting compared with non-diabetic AMI patients with PR.
|
|
|
|